Ageing, sickness and death are almost irresistible laws of nature for human beings, and what is closely linked to ageing is sickness. It is well known that people's resistance decreases as they get older, and it is a fact that old people get sick more often than not. And in the face of disease, medicine has become the most "just" demand.
Pharmaceutical industry development is stable:
In 2016, the pharmaceutical industry enterprises above designated size realized 2963.9 billion yuan of revenue from main business, an increase of 9.92% year-on-year, the growth rate of the same period of the previous year increased by 0.90 percentage points, the growth rate of the country's overall growth rate is higher than 5.02 percentage points.
According to Foresight Industry Research Institute's China Pharmaceutical Industry In-depth Research and Investment Strategy Planning Analysis Report, the fastest-growing pharmaceutical subsector is the manufacturing of medical instruments, equipment, and devices.In 2016, enterprises above the scale of the pharmaceutical industry realized a total profit of 321,643 million yuan with a year-on-year growth of 15.57%, a growth rate of 3.35 percentage points higher than the same period of the previous year.
In January-April 2017, the pharmaceutical manufacturing industry realized main business income of 912.4 billion yuan, an increase of 11.2%; total profit of 97.6 billion yuan, an increase of 14.5%; income growth rate improved year-on-year. 237.5 billion yuan of income and 25.8 billion yuan of total profit in a single month in April.
Chart: 2010-2016 China's pharmaceutical industry sales revenue and growth rate trend (unit: billion yuan, %)
Source: National Bureau of Statistics Forward Industry Research Institute
Domestic drug companies to enhance the strength of research and development, and gradually expand market share in the world:
In the past we Witnessed the rise of many industries: domestic home appliances from scratch, and now basically dominate the market, exported to all over the world; Chinese companies entered the photovoltaic industry monopolized by developed countries, and now all the mainstream foreign producers to beat bankruptcy; smartphone industry, although the years are still short, but the rise of the speed of the speed of the amazing, foreign brands continue to be compressed market share; automotive industry, the rise of the also be visible! The rise of the automobile industry is also visible, domestic SUVs are soaring, and the market share of independent brands is rising.
A large part of the reason for the rise of the above domestic industry is our national character, but also the process of technological accumulation, the inevitable result of quantitative to qualitative change. Similarly, the high margin nature of pharmaceutical manufacturing determines that there must be a part of the Chinese companies continue to try to share the profits of the international giants. This process is as unstoppable as the aging of China's population.
Chart: China's pharmaceutical giants
Source: Prospect Industry Research Institute
The future of the pharmaceutical industry is so certain, and so fascinating. And those Chinese pharmaceutical companies with deep accumulation of technology and strong R&D strength will get more dividends from the industry in the future. The details of the future development of the pharmaceutical industry is not clear now, but like a big river, but can determine its forward direction, which is undoubtedly wonderful.